UK Drugs Legislation since 1971
OpenAlex – July 22, 2022
Source: OpenAlex
Summary
The UK's approach to drug legislation has seen significant, often contentious, shifts. Before 2005, cultivating 'magic mushrooms' was not an offense; however, the Drugs Act 2005 criminalized possession of psychoactive fungi. Further laws, including the 2016 Psychoactive Substances Act, aimed to control new drugs. This legislation faced criticism due to the difficulty in forensic toxicology and drug analysis to demonstrate psychoactivity, posing ongoing challenges for criminology and political science in managing drug policy and pharmacology.
Abstract
Concurrent with the Misuse of Drugs Act 1971 (MDAct), several further pieces of legislation were introduced, principally the Drugs Act 2005, Temporary Class Drug Orders 2011 (TCDOs) and the Psychoactive Substances Act 2016 (PSA). Before 2005, the cultivation of ‘magic mushrooms’ was not an offence. Whether a person was in possession of such mushrooms depended on whether they were in possession of a preparation containing a controlled drug. This was such a contentious issue that the Drugs Act 2005 made possession of fungi containing psilocin or an ester of psilocin an offence. Other parts of the Drugs Act which were intended to deal with the concept of threshold amounts, above which an offence might be committed, were deemed to be unworkable and never implemented. TCDOs were introduced by the Police Reform and Social Responsibility Act 2011. They allowed substances to be placed under temporary control for one year, after which control would either be relinquished or the substances would be included in the MDAct. The PSA was the United Kingdom's response to the plethora of NPS that were being used. This legislation received much criticism for a number of reasons, one of which was the difficulty of demonstrating that a given substance was psychoactive. A number of other Acts have an indirect bearing on controlled drug offences.